ID Biomedical Corporation, Quebec Report issue

For profit Phase 3
Founded: Vancouver Canada (1991)
Status: Acquired by GlaxoSmithKline (2005)

Organization Overview

First Clinical Trial
2005
NCT01389479
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ID Biomedical Corporation of Quebec | ID Biomedical of Quebec

Active Ingredients

Drugs in Phase 3 Trials (1)

inactivated influenza vaccine (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1